DOI: 10.1055/s-00000116

Seminars in Vascular Medicine

Issue 03 · Volume 5 · August 2005 DOI: 10.1055/s-002-4308 Ximelagatran as a New Oral Anticoagulant for Thrombosis Editor in Chief Jan Jacques Michiels M.D. Ph.D., Guest Editors Ola E Dahl M.D. Ph.D.

C1
Review Questions
227
Gustafsson, David: Discovery of Ximelagatran in an Historical Perspective
235
Mattsson, Christer; Sarich, Troy C.; Carlsson, Stefan C.: Mechanism of Action of the Oral Direct Thrombin Inhibitor Ximelagatran
245
Wolzt, Michael; Sarich, Troy S.; Eriksson, Ulf G.: Pharmacokinetics and Pharmacodynamics of Ximelagatran
254
Wolzt, Michael; Sarich, Troy S.; Eriksson, Ulf G.: Low Potential for Interactions Between Melagatran/Ximelagatran and Other Drugs, Food, or Alcohol
259
Carlsson, Stefan C.; Schulman, Sam: A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran
266
Colwell, Clifford; Mouret, Patrick: Ximelagatran for the Prevention of Venous Thromboembolism Following Elective Hip or Knee Replacement Surgery
276
Huisman, Menno V.; Bounameaux, Henri: Treating Patients with Venous Thromboembolism: Initial Strategies and Long-Term Secondary Prevention
285
Olsson, S. Bertil; Halperin, Jonathan L.: Prevention of Stroke in Patients with Atrial Fibrillation
293
Wallentin, Lars: Prevention of Cardiovascular Events after Acute Coronary Syndrome
301
Schulman, Sam; Lip, Gregory Y. H.: Ximelagatran in the Clinic: Practical Management of Patients

PREFACE

223
Dahl, Ola E.; Michiels, Jan Jacques: Ximelagatran as a New Oral Anticoagulant for Thrombosis